Alumni raised $1.45B in 2022 - Download Free Report Now

Vigilant Biosciences

Low-cost, point-of-care (POC) ELISA-based adjunctive screening kit specifically for oral cancer.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Vigilant Biosciences plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Vigilant Biosciences

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With